ResearcherHeidelberg UniversityActive in the last 2 years
Lian Zhao
Matched on ORCID iD 0009-0003-4328-6539; OpenAlex author ID A5028493842. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Baicalein disrupts TGF-β-induced EMT in pancreatic cancer by FTO-dependent m6A demethylation of ZEB1. Co-author DOI 10.1016/j.bbamcr.2025.119969↗
- Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.matbio.2022.11.002↗
- UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis. Co-author DOI 10.3389/fonc.2022.834647↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bin Yan · 3 shared papers, 2022–2025 · strength 0.59
- Paper Baicalein disrupts TGF-β-induced EMT in pancreatic cancer by FTO-dependent m6A demethylation of ZEB1. DOI 10.1016/j.bbamcr.2025.119969↗
- Paper UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis. DOI 10.3389/fonc.2022.834647↗
- Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
- Ingrid Herr · 3 shared papers, 2022–2025 · strength 0.59
- Paper Baicalein disrupts TGF-β-induced EMT in pancreatic cancer by FTO-dependent m6A demethylation of ZEB1. DOI 10.1016/j.bbamcr.2025.119969↗
- Paper UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis. DOI 10.3389/fonc.2022.834647↗
- Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
- Yiqiao Luo · 2 shared papers, 2022 · strength 0.30
- Michael Schaefer · 1 shared paper, 2025 · strength 0.28
- Chen Gong · 1 shared paper, 2025 · strength 0.28
- Kangtao Wang · 1 shared paper, 2025 · strength 0.28
- Xuefeng An · 1 shared paper, 2022 · strength 0.13
- Franco Fortunato · 1 shared paper, 2022 · strength 0.13
- Matthias M. Gaida · 1 shared paper, 2022 · strength 0.13
- Li Liu · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.